FDA limits COVID-19 vaccine to those at risk of severe disease in new approvals

Published August 27, 2025 2:22pm ET



The Food and Drug Administration approved COVID-19 vaccine doses for the fall and winter season on Wednesday — but with limitations that will likely hinder access for millions of people.

The agency granted approval for COVID-19 vaccine doses for people over age 65, who are most vulnerable to severe infections, but younger people will only be eligible if they have at least one underlying medical condition that puts them at higher risk for hospitalization or death. Younger people without such conditions could have trouble getting the shot.

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.